e-learning
resources
Milan 2017
Wednesday, 13.09.2017
From idiopathic pulmonary fibrosis (IPF) to rare diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of free fatty acids in idiopathic pulmonary fibrosis
Source:
International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Session:
From idiopathic pulmonary fibrosis (IPF) to rare diseases
Session type:
Oral Presentation
Number:
4635
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
The role of free fatty acids in idiopathic pulmonary fibrosis. 4635
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth
Source: Eur Respir J 2015; 46: 1033-1045
Year: 2015
Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale
Source: Eur Respir J 2001; 18: Suppl. 33, 251s
Year: 2001
Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2008; 31: 1024-1029
Year: 2008
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007
Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006
Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis
Source: Eur Respir J 2007; 29: 958-964
Year: 2007
Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults With cystic fibrosis?
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Aging decreases pulmonary fibrosis reversibility via remodeling fatty acid metabolism of fibroblasts modulated by PRDM16
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Omega-3 polyunsaturated fatty acids in correction of hemostasis system in patients with cor pulmonale
Source: Eur Respir J 2002; 20: Suppl. 38, 100s
Year: 2002
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 145s
Year: 2007
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids?
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001
Essential phospholipids in pulmonary sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017
A first step against idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 130-131
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept